These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 11242051)

  • 1. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
    Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
    Ellefsen K; Harari A; Champagne P; Bart PA; Sékaly RP; Pantaleo G
    Eur J Immunol; 2002 Dec; 32(12):3756-64. PubMed ID: 12516570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cell effector maturation in HIV-1-infected children.
    Jordan KA; Furlan SN; Gonzalez VD; Karlsson AC; Quigley MF; Deeks SG; Rosenberg MG; Nixon DF; Sandberg JK
    Virology; 2006 Mar; 347(1):117-26. PubMed ID: 16406047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.
    Tomiyama H; Takata H; Matsuda T; Takiguchi M
    Eur J Immunol; 2004 Apr; 34(4):999-1010. PubMed ID: 15048710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
    Kobayashi N; Takata H; Yokota S; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.
    Zimmerli SC; Harari A; Cellerai C; Vallelian F; Bart PA; Pantaleo G
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7239-44. PubMed ID: 15872023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated changes in the frequency of naïve, memory and effector CD8+ T cells.
    Hong MS; Dan JM; Choi JY; Kang I
    Mech Ageing Dev; 2004 Sep; 125(9):615-8. PubMed ID: 15491679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation.
    Viallard JF; Blanco P; André M; Etienne G; Liferman F; Neau D; Vidal E; Moreau JF; Pellegrin JL
    Clin Immunol; 2006 Apr; 119(1):51-8. PubMed ID: 16413828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3.
    Kobayashi N; Kondo T; Takata H; Yokota S; Takiguchi M
    J Leukoc Biol; 2006 Aug; 80(2):320-9. PubMed ID: 16861617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
    Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
    Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic classification of human CD4+ T cell subsets and their differentiation.
    Okada R; Kondo T; Matsuki F; Takata H; Takiguchi M
    Int Immunol; 2008 Sep; 20(9):1189-99. PubMed ID: 18635582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.
    Ravkov EV; Myrick CM; Altman JD
    J Immunol; 2003 Mar; 170(5):2461-8. PubMed ID: 12594271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+) T-cell immunity to cytomegalovirus.
    Moss P; Khan N
    Hum Immunol; 2004 May; 65(5):456-64. PubMed ID: 15172445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression.
    Perez-Patrigeon S; Vingert B; Lambotte O; Viard JP; Delfraissy JF; Thèze J; Chakrabarti LA
    AIDS; 2009 Jun; 23(10):1197-207. PubMed ID: 19455014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
    Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal peripheral T-cell lymphomas correspond to distinct mature T-cell populations.
    Geissinger E; Bonzheim I; Krenács L; Roth S; Reimer P; Wilhelm M; Müller-Hermelink HK; Rüdiger T
    J Pathol; 2006 Oct; 210(2):172-80. PubMed ID: 16924587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF; Price P; French MA
    J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
    Valmori D; Scheibenbogen C; Dutoit V; Nagorsen D; Asemissen AM; Rubio-Godoy V; Rimoldi D; Guillaume P; Romero P; Schadendorf D; Lipp M; Dietrich PY; Thiel E; Cerottini JC; Liénard D; Keilholz U
    Cancer Res; 2002 Mar; 62(6):1743-50. PubMed ID: 11912149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.